SRSF3 and chronic myelogenous leukemia, BCR-ABL1 positive: We obtained similar results in primary CP-CML CD34+ cells (n = 4 patients) (Supplemental Table S1) incubated with 5 μM of nilotinib for 6 days, with five genes deregulated: PHD finger protein 5A (PHF5A), PTBP1, SRSF1, SRSF3, and SRSF10 (Table 1).